HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,090,051 | +16.0% | 36,732 | -10.2% | 0.43% | -1.6% |
| Q2 2022 | $1,801,000 | +17.8% | 40,923 | +11.6% | 0.44% | +91.3% |
| Q1 2021 | $1,529,000 | +7.3% | 36,678 | +10.0% | 0.23% | -1.3% |
| Q4 2020 | $1,425,000 | -0.4% | 33,357 | -38.7% | 0.23% | -31.3% |
| Q3 2020 | $1,431,000 | -37.3% | 54,452 | -36.0% | 0.34% | -32.9% |
| Q2 2020 | $2,283,000 | -36.4% | 85,144 | -46.4% | 0.50% | +20.2% |
| Q2 2015 | $3,589,000 | +12.0% | 158,947 | -29.2% | 0.42% | +13.5% |
| Q1 2015 | $3,204,000 | – | 224,384 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |